Systems pharmacology, pharmacogenetics, and clinical trial design in network medicine.

Wiley Interdisciplinary Reviews. Systems Biology and Medicine
Elliott AntmanJoseph Loscalzo

Abstract

The rapidly growing disciplines of systems biology and network science are now poised to meet the fields of clinical medicine and pharmacology. Principles of systems pharmacology can be applied to drug design and, ultimately, testing in human clinical trials. Rather than focusing exclusively on single drug targets, systems pharmacology examines the holistic response of a phenotype-dependent pathway or pathways to drug perturbation. Knowledge of individual pharmacogenetic profiles further modulates the responses to these drug perturbations, moving the field toward more individualized ('personalized') drug development. The speed with which the information required to assess these system responses and their genomic underpinnings is changing and the importance of identifying the optimal drug or drug combinations for maximal benefit and minimal risk require that clinical trial design strategies be adaptable. In this paper, we review the tenets of adaptive clinical trial design as they may apply to an era of expanding knowledge of systems pharmacology and pharmacogenomics, and clinical trail design in network medicine.

References

Jul 1, 1989·Clinical Pharmacology and Therapeutics·L B SheinerN C Sambol
Sep 13, 1996·Science·N Risch, K Merikangas
Oct 25, 1996·Science·E S Lander
Mar 1, 1997·Clinical Pharmacology and Therapeutics·L B Sheiner
Aug 6, 1997·Journal of the National Cancer Institute·R SimonM C Christian
Aug 15, 1998·The New England Journal of Medicine·UNKNOWN Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigato
Apr 28, 2001·Trends in Molecular Medicine·B B SpearJ Huff
May 22, 2001·British Medical Bulletin·J M DrazenT H Lee
Aug 25, 2001·The New England Journal of Medicine·S YusufUNKNOWN Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators
Aug 30, 2001·Revista Portuguesa De Cardiologia : Orgão Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology·H Pereira, UNKNOWN GUSTO V Investigators
Feb 28, 2003·Journal of Health Economics·Joseph A DiMasiHenry G Grabowski
Apr 4, 2003·The New England Journal of Medicine·Franklin G Miller, Donald L Rosenstein
Oct 4, 2003·Nature Reviews. Drug Discovery·Mark A Lindsay
Apr 3, 2004·Nature Reviews. Drug Discovery·Michael D Rawlins
May 8, 2004·Nature Reviews. Genetics·John S Mattick
Nov 9, 2004·The New England Journal of Medicine·Eugene BraunwaldUNKNOWN PEACE Trial Investigators
Nov 12, 2005·Journal of Pharmacokinetics and Pharmacodynamics·Raymond MillerRichard L Lalonde
Nov 25, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·M John Chapman, Alain Carrie
Feb 18, 2006·Nature Reviews. Drug Discovery·Donald A Berry
Mar 29, 2006·The Pharmacogenomics Journal·S T WeissK G Tantisira
May 4, 2006·The Journal of Pharmacology and Experimental Therapeutics·Ronald J Tallarida
May 27, 2006·Journal of Biopharmaceutical Statistics·Paul GalloUNKNOWN PhRMA Working Group
Aug 19, 2006·Nature Reviews. Drug Discovery
Aug 22, 2006·Nature Chemical Biology·Jonathan B FitzgeraldPeter K Sorger
Sep 16, 2006·Biometrical Journal. Biometrische Zeitschrift·H M James HungJohn Lawrence
Sep 16, 2006·Biometrical Journal. Biometrische Zeitschrift·Cyrus R Mehta, Yannis Jemiai
Sep 16, 2006·Journal of Biomolecular Screening·Sandra FoxMichael Biros
Nov 4, 2006·Pharmaceutical Statistics·Paul Gallo
Jan 30, 2007·Clinical Pharmacology and Therapeutics·L J Lesko
Mar 3, 2007·Molecular Systems Biology·Joseph LehárCurtis T Keith
Mar 3, 2007·Molecular Systems Biology·Pamela Yeh, Roy Kishony
May 6, 2008·Orphanet Journal of Rare Diseases·Shein-Chung Chow, Mark Chang
Aug 7, 2008·Pharmacogenomics·Catherine Buettner, Stewart H Lecker
Sep 23, 2008·Cell·Thomas P Stossel
Nov 26, 2008·Nature Immunology·Troy D QuerecBali Pulendran
Feb 4, 2009·Circulation·Cyrus MehtaJames H Ware
Feb 12, 2009·Statistics in Medicine·Frank BretzMartin Posch
Feb 28, 2009·Health Economics·Christopher Paul Adams, Van Vu Brantner
May 15, 2009·Clinical Pharmacology and Therapeutics·A D BarkerL J Esserman
Aug 1, 2009·American Journal of Respiratory and Critical Care Medicine·Jacqueline GambleLiam G Heaney

❮ Previous
Next ❯

Citations

Oct 22, 2013·Trends in Pharmacological Sciences·Xuan LiuDe-An Guo
Jul 24, 2012·Circulation Research·Stephen Y Chan, Joseph Loscalzo
Dec 5, 2013·Omics : a Journal of Integrative Biology·Konstantina DimitrakopoulouAnastasios Bezerianos
Aug 21, 2012·Cellular and Molecular Life Sciences : CMLS·Miguel Ángel Medina
Nov 28, 2012·Wiley Interdisciplinary Reviews. Systems Biology and Medicine·Rui Chen, Michael Snyder
Nov 12, 2013·Wiley Interdisciplinary Reviews. Systems Biology and Medicine·Drieke VandammeWalter Kolch
Mar 18, 2015·Wiley Interdisciplinary Reviews. Systems Biology and Medicine·Ioannis P Androulakis
Apr 22, 2015·Wiley Interdisciplinary Reviews. Systems Biology and Medicine·Rui-Sheng WangJoseph Loscalzo
Apr 18, 2015·Trends in Molecular Medicine·Kathryn T HallTed J Kaptchuk
Oct 9, 2014·Annual Review of Pharmacology and Toxicology·Heung-Woo ParkScott T Weiss
Jul 1, 2016·Nature Reviews. Cardiology·Elliott M Antman, Joseph Loscalzo
Apr 18, 2015·Circulation·Caroline S FoxUNKNOWN American Heart Association Council on Functional Genomics and Translational Biology, Council on Cardiovascular and Stroke Nu
Nov 7, 2015·Journal of the American Heart Association·Elliott M AntmanUNKNOWN American Heart Association Data Sharing Summit Attendees
Jun 22, 2016·Circulation·Calum A MacRaeJoseph Loscalzo
Jan 12, 2019·Journal of Immunoassay & Immunochemistry·Maria-Linda PopaCristiana Tanase
May 20, 2014·Circulation Journal : Official Journal of the Japanese Circulation Society·Elliott M Antman
Apr 17, 2013·Current Opinion in Allergy and Clinical Immunology·Ioana O Agache
Oct 18, 2019·Nature Reviews. Clinical Oncology·James T YurkovichLeroy Hood
Jan 3, 2020·The Journal of Clinical Investigation·Jane A LeopoldJoseph Loscalzo
Oct 23, 2020·Journal of Personalized Medicine·Gizem Damla YalcinAhmet Acar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Mount Sinai Journal of Medicine, New York
Aislyn D W Boran, Ravi Iyengar
The Journal of Physiology
Michael J Joyner, Bente K Pedersen
Current Drug Discovery Technologies
Osama M AlianRamzi M Mohammad
© 2021 Meta ULC. All rights reserved